Arkansas Children's Hospital

2026–2027 · program · P20

Growing Healthy Children and Families in Rural Arkansas

Martha Rojo · Arkansas Children's Hospital · funded by National Institutes of Health

2025–2030 · research · R01

Evaluating Maternal and Neonatal Pharmacokinetics of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators - The ELECTRA Pregnancy Study

Jennifer S Guimbellot · Arkansas Children's Hospital · funded by National Institutes of Health

$696.2k

2025–2027 · program · P20

Intersection of Uremic Toxins and Biological Sex in Chronic Kidney Disease Progression

Joseph Lee Alge · Arkansas Children's Hospital · funded by National Institutes of Health

2024–2029 · research · R01

An Integrated Host-Microbe Gene Classifier to Predict SARS-CoV-2 and Severe Disease in Children with Respiratory Viral Coinfections

Joshua Kennedy · Arkansas Children's Hospital · funded by National Institutes of Health

$694.4kRespiratory viral infections research

2024–2028 · career development · K23

Multifactorial Asthma Determinants in Underresourced Pediatric Populations

Akilah Andrea Jefferson · Arkansas Children's Hospital · funded by National Institutes of Health

$164.5kAsthma and respiratory diseases

2024–2029 · research · R01

ENsuring ACcess to optimal Therapy in CF: ENACT study

Jennifer S Guimbellot · Arkansas Children's Hospital · funded by National Institutes of Health

$642.5kCystic Fibrosis Research Advances

2024–2029 · research · R01

Calcineurin Control over Aspergillus Fumigatus Antifungal Response Mechanisms

Praveen Rao Juvvadi · Arkansas Children's Hospital · funded by National Institutes of Health

$521.4kSignaling Pathways in Disease

2024–2029 · research · R01

Next Generation Treatments for Lymphatic Malformations

Graham M Strub · Arkansas Children's Hospital · funded by National Institutes of Health

$684.7kVascular Malformations and Hemangiomas

2024–2031 · cooperative agreement · U01

Arkansas Center for Food Allergy Research (ArCOFAR)

Stacie M Jones · Arkansas Children's Hospital · funded by National Institutes of Health

$340kFood Allergy and Anaphylaxis Research

2024–2026 · research · R21

PKA-Dependent Autophagy Control in Aspergillus fumigatus Pathogenesis

Praveen Rao Juvvadi · Arkansas Children's Hospital · funded by National Institutes of Health

$251.1kAutophagy in Disease and Therapy

2024–2025 · research · R24

Promoting Rigor and Reproducibility in Rodent Models of Metabolic Disease through Thermoneutral Housing

Craig Porter · Arkansas Children's Hospital · funded by National Institutes of Health

$342.8k

2024 · research · CARRA-Arthritis Foundation CARRA Small Grant

The Impact of Skin Disease on Self-Reported Quality of Life and Psychosocial Health in Youth with Cutaneous Lupus Erythematosus

Alexandra Theisen · Arkansas Children's Hospital · funded by Arthritis Foundation

2024–2027 · research · R21

PKA-Dependent Autophagy Control in Aspergillus fumigatus Pathogenesis

Praveen Rao Juvvadi · Arkansas Children's Hospital · funded by National Institutes of Health

$212.1k

2024–2031 · cooperative agreement · U01

Arkansas Center for Food Allergy Research (ArCOFAR)

Stacie M Jones · Arkansas Children's Hospital · funded by National Institutes of Health

$300.3k

2024–2029 · research · R01

Deimplementation of Inappropriate Feeding Practices in Early Care andEducation Settings

Julie Rutledge · Arkansas Children's Hospital · funded by National Institutes of Health

$613.8k

2024–2028 · career development · K23

Multifactorial Asthma Determinants in Underresourced Pediatric Populations

Akilah Andrea Jefferson · Arkansas Children's Hospital · funded by National Institutes of Health

$168.2k

2024–2029 · research · R01

An Integrated Host-Microbe Gene Classifier to Predict SARS-CoV-2 and Severe Disease in Children with Respiratory Viral Coinfections

Joshua Kennedy · Arkansas Children's Hospital · funded by National Institutes of Health

$667.6k

2024–2029 · research · R01

ENsuring ACcess to optimal Therapy in CF: ENACT study

Jennifer S Guimbellot · Arkansas Children's Hospital · funded by National Institutes of Health

$592.3k

2024–2029 · research · R01

Calcineurin Control over Aspergillus Fumigatus Antifungal Response Mechanisms

Praveen Rao Juvvadi · Arkansas Children's Hospital · funded by National Institutes of Health

$503.7k

2024–2029 · research · R01

Perinatal PFAS Impact Children's Development: Examining the Roles of Placental Functional Multiomics and Protection by Maternal Exercise

Aline Andres · Arkansas Children's Hospital · funded by National Institutes of Health

$695.9k

2024–2031 · cooperative agreement · U01

Arkansas Center for Food Allergy Research (ArCOFAR)

Stacie M Jones · Arkansas Children's Hospital · funded by National Institutes of Health

$339.5k

2024–2029 · research · R01

Next Generation Treatments for Lymphatic Malformations

Graham M Strub · Arkansas Children's Hospital · funded by National Institutes of Health

$640.4k

2023–2027 · grant · Standard Grant

SCISIPBIO: Maximizing the Value of Sex-Inclusive Research Policies through Analytical Rigor

Andrew Brown · Arkansas Children's Hospital · funded by National Science Foundation

$264.4k

2023–2025 · research · R21

DNA-PKcs Regulation of LAT-Mediated Early TCR Signaling in CD4+ and CD8+ T Cells

Marie Schluterman Burdine · Arkansas Children's Hospital · funded by National Institutes of Health

$231k

2023–2027 · fellowship · F30

Altered miRNA Expression Drives Proliferation of Lymphatic Malformation by Activating Pro-Growth Signaling Cascades

Ravi Sun · Arkansas Children's Hospital · funded by National Institutes of Health

$38kVascular Malformations and Hemangiomas

2023–2027 · fellowship · F30

Altered miRNA Expression Drives Proliferation of Lymphatic Malformation by Activating Pro-Growth Signaling Cascades

Ravi Sun · Arkansas Children's Hospital · funded by National Institutes of Health

$39.4kVascular Malformations and Hemangiomas

2023–2025 · research · R21

DNA-PKcs Regulation of LAT-Mediated Early TCR Signaling in CD4+ and CD8+ T Cells

Marie Schluterman Burdine · Arkansas Children's Hospital · funded by National Institutes of Health

$192.5k

2023–2028 · career development · K23

Salivary miRNAs as Prognostic Markers of Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia in Extremely Low Gestational Age Infants

Roopa Siddaiah · Arkansas Children's Hospital · funded by National Institutes of Health

$159.4k

2023–2027 · fellowship · F30

Altered miRNA Expression Drives Proliferation of Lymphatic Malformation by Activating Pro-Growth Signaling Cascades

Ravi Sun · Arkansas Children's Hospital · funded by National Institutes of Health

$54.5k

2022–2029 · research · R01

Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial

Brian T Fisher · Arkansas Children's Hospital · funded by National Institutes of Health

$1.4MAntifungal resistance and susceptibility

2022–2029 · research · R01

Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial

Brian T Fisher · Arkansas Children's Hospital · funded by National Institutes of Health

$1.5MAntifungal resistance and susceptibility

2022–2027 · research · R37

Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia

Ellen Van Der Plas · Arkansas Children's Hospital · funded by National Institutes of Health

$531.9kCancer-related cognitive impairment studies

2022–2027 · research · R37

Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia

Ellen Van Der Plas · Arkansas Children's Hospital · funded by National Institutes of Health

$475.3kCancer-related cognitive impairment studies

2022–2027 · research · R37

Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia

Ellen Van Der Plas · Arkansas Children's Hospital · funded by National Institutes of Health

$489.1kCancer-related cognitive impairment studies

2022–2029 · research · R01

Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial

Brian T Fisher · Arkansas Children's Hospital · funded by National Institutes of Health

$1.4MAntifungal resistance and susceptibility

2022–2029 · research · R01

Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial

Brian T Fisher · Arkansas Children's Hospital · funded by National Institutes of Health

$28.4k

2022–2029 · research · R01

Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial

Brian T Fisher · Arkansas Children's Hospital · funded by National Institutes of Health

$28.4k

2022–2029 · research · R01

Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial

Brian T Fisher · Arkansas Children's Hospital · funded by National Institutes of Health

$28.4k

2022–2029 · research · R01

Short Course Versus Standard Course Antifungal Therapy for Pediatric Candidemia: A Multi-Center Randomized Controlled Trial

Brian T Fisher · Arkansas Children's Hospital · funded by National Institutes of Health

$1.2M

2022–2027 · research · R37

Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia

Ellen Van Der Plas · Arkansas Children's Hospital · funded by National Institutes of Health

$559.5k